Previous editions > Schedule 2022

09:00 - 09:30 Welcome, coffee

09:30 - 10:30  Session 1 : Review of the 2019 evaluation and perspectives 

• Simone Mergui, NeurATRIS Executive Director
• Philippe Hantraye, NeurATRIS Scientific Director

10:30 - 13:00  Session 2 : Scientific results

10:30 - 11:00 WP1 Cell therapy

10h30 - 10h40: Overview by Anne-Catherine Bachoud Levi and Anselme Perrier

10h40- 10h50: Marine Lunven, NPI-ENS: “New line of Digitalised assessments in cognition in Huntington's disease”

10h50- 11h00: Rachid Riad, LSCP/ NPI-ENS: “Voice analysis for predicting the clinical score in Huntington's disease »

11:00 - 11:30 Coffee break

11:30 - 11:50 WP2 Gene therapy

11h30- 11h40: Overview by Marie-Anne Colle

11h40-11h50: Françoise Piguet, ICM: "Intravenous gene therapy for metachromatic leukodystrophy"     

11:50 - 12:30 WP3 Functional analysis and in vivo assessment

11h50- 11h55: Short introduction by Philippe Hantraye

11h55- 12h05: Nadège Sarrazin, ICM:« Failed remyelination of the nonhuman primate optic nerve leads to axon degeneration, retinal damages, and visual dysfunction”

12h05- 12h30: Céline Baligand, CEA-MIRcen: “New methodological developments in oxygen-17 MRI”

 12:30 - 13:00 WP4 Drug based therapy 

12h30- 12h40: Overview by Brahim Nait Oumesmar

12h40- 12h50: Cindy Bokobza, NeuroDiderot: “Targeting the brain 5-HT7 receptor to prevent hypomyelination in a rodent model of perinatal white matter injuries”

12h50- 13h00: Nadjet Gacem, ICM: “Identification of Novel Repurposing Drugs for Myelin Regeneration Therapeutics in Multiple Sclerosis”

13:00 - 14:00 Lunch 

14:00 - 15:15  Session 3 : Selected projects from NeurATRIS Call

14h00- 14h15: Sylvie Remaud, MNHN: “Impact of Endocrine-disrupting chemicals on remyelination”

14h15- 14h30: Brahim Nait Oumesmar, ICM: “Glial Cells Missing transcription factors: An anti-inflammatory function conserved from flies to humans”

14h30- 14h45: Cendra Agulhon, INC: “Satellite glial cell-proprioceptor interactions: implications for spinal muscular atrophy,amyotrophic lateral sclerosis and Friedreich’s ataxia”

14h45- 15h00: Pierre Gressens, NeuroDiderot: “Regulation of microglial activation by omega3: a novel and targetable mechanism in neurodevelopmental disorders”

15h00 - 15h15: Fernanda Marques, ICVS- University of Minho: “Metabolic Reprogramming in the EAE mouse model of Multiple Sclerosis”

15:15 - 15:45 Coffee break

15:45 - 16:30 Presentation of EATRIS, the European Infrastructure for Translational Research by Toni Andreu, EATRIS Scientific Director   

16:30 - 16:45 Conclusion by Bernard Zalc, Deputy Scientific Director of NeurATRIS, ICM

          End of the meeting for attendees except COMEX and SAB

 16:45 - 17h30 Feedback from SAB and discussion between SAB and NeurATRIS members

------------------------------------------------------------------------------------------------------------------------------------------------------------------------The NeurATRIS general meeting 2022 has been taking place on December 05, 2022 from 9:00AM to 4:45PM at the Cité Internationale Universitaire de Paris, in the Salon Honorat of the Maison Internationale.